CD47 and neoplasm: The interference with CD47–SIRPα interaction synergized with tumor-specific monoclonal antibodies enhanced macrophage-mediated antibody-dependent cellular phagocytosis (ADCP), leading to the elimination of human tumor xenografts in mice [137].